Please login to the form below

Not currently logged in


This page shows the latest ADHD news and features for those working in and with pharma, biotech and healthcare.

Latest news

More from news
Approximately 15 fully matching, plus 126 partially matching documents found.

Latest Intelligence

  • Sourcing R&D innovation: why pharma companies need to evolve their business models Sourcing R&D innovation: why pharma companies need to evolve their business models

    With recent FDA approval of EndeavorRx by Akili, a ‘first of its kind attention treatment for children with ADHD delivered through a captivating video game experience’, and multiple innovative technologies in

  • Deal Watch March 2017 Deal Watch March 2017

    contingent payments for the ADHD company Neurovance; Shanghai Fosun paid $90m for a majority interest in Breas (see above); Ascendis Health paid R375m ($29m) for the Southern Africa operations of Cipla ... 320. Neurovance. Otsuka. Acquisition. Portfolio,

  • A rare talent A rare talent

    It allowed us to solidify our position as the world's largest rare disease company and we now are the leaders in haematology, lysosomal storage disorders with strong capabilities in ADHD

  • Challenging perceptions Challenging perceptions

    We try to be recognised as patient-centric by supporting and helping the overall ADHD community. ... Harnessing technology. Shire's communications efforts in ADHD have for some time included digital technology.

  • Pharma deals in February 2015 Pharma deals in February 2015

    in-house clinical and preclinical pipeline targeting serious diseases with blockbuster potential eg Alzheimer's disease, ADHD, metabolic disease, schizophrenia, migraine. ... Its initial development was focused on ADHD and other neurological diseases.

More from intelligence
Approximately 1 fully matching, plus 9 partially matching documents found.

Latest appointments

  • Shire elects new chair Shire elects new chair

    During that time Shire has grown substantially, although has struggled in recent years with generic competition for big-selling attention deficit-hyperactivity disorder (ADHD) drug Adderall XR and plans to downsize

  • Bray Leino opens health and wellbeing PR practice Bray Leino opens health and wellbeing PR practice

    She has worked on campaigns for ADHD brands and public affairs for Shire Pharmaceuticals: cardiology products for AstraZeneca, Sanofi and Eli Lilly; mental health for Wyeth; diagnostics and devices for Roche

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Virtual MSL training on the Impetus InSite Platform®: A Customer Story

    Enhance the MSLs’ understanding of new data and key studies on the treatment options for ADHD.

  • A personal perspective on autism

    In many ways, you wouldn’t immediately be able to tell my older son is on the spectrum, yet he is diagnosed with Aspergers attention deficit hyperactivity disorder (ADHD).

  • Mednet Group Mednet Group

    For ADHD awareness month this year our Associate Medical Writer, Alex Teahan, has written a piece surrounding ADHD and employment. ... He discusses the advantages and disadvantages of ADHD at work, and areas of improvement for employers in supporting

  • PANDAS/PANS Awareness: A parent’s story

    As PANDAS is an autoimmune disease that leads to inflammation in the basal ganglia region of the brain, the symptoms (including head shakes, OCD, ADHD and vocal tics), tend to reappear

  • Neurodiversity, ADHD and work: Obstacles and opportunities

    2006). Characterizing cognition in ADHD: beyond executive dysfunction. Trends in cognitive sciences,  10(3), 117-123. ... 12. Hupfeld, K. E., Abagis, T. R., &Shah, P. (2018). Living “in the zone”: hyperfocus in adult ADHD. ADHD Attention Deficit

More from PMHub
Approximately 2 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is an award-winning, independent agency founded in 2011. We partner with healthcare professionals, patients, and global pharmaceutical...

Latest intelligence

Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare